热门资讯> 正文
罗氏开始对89 bio进行要约收购，作为收购的一部分
2025-10-02 05:30
- 89bio(ETNB) 0
- 团车网(TC) 0
- 罗氏(ADR)(RHHBY) 0
- Roche (OTCQX:RHHBY) has begun a tender offer for all shares of 89bio (NASDAQ:ETNB) as part of the Swiss pharma's up to $3.5B acquisition deal that was announced in September.
- Details call for $14.50 per share of 89bio in cash, as well as a non-tradeable contingent value right to receive certain milestone payments of up to an aggregate of $6.00 per share.
- The offer expires at midnight on Oct. 30, unless it is extended.
More on Roche
- Roche's Giredestrant: A Ray Of Hope On A Cloudy Horizon?
- Roche Holding AG (RHHBY) Discusses On Pharma Day 2025 (Transcript)
- Roche Holding AG (RHHBY) Special Call - Slideshow
- Novo Nordisk, Roche gain upgrades from HSBC
- Pfizer – U.S. drug pricing deal boosts EU drugmakers
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
